Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
100201600----1件: 229 💬
2[NA]----34件: 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
3Baseline WLL----1件: 229 💬
4Blood Collection----5件: 21, 65, 201, 229, 271 💬
5Bronchoalveolar lavage fluid collection----1件: 229 💬
6Centricyte 1000----2件: 85, 229 💬
7Diagnostic Test: Abdominal and liver ultrasound.----1件: 229 💬
8Diagnostic Test: Brain MRI----2件: 25, 229 💬
9Diagnostic Test: Methionine/homocysteine Dosage2件: Homocysteine,
Methionine		1件: Methionine 💬 --1件: 229 💬
10Diagnostic Test: Thoracic CT scan----1件: 229 💬
11GM-CSF----3件: 51, 60, 229 💬
12GM-CSF (granulocyte-macrophage colony-stimulating factor)----1件: 229 💬
13GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)1件: Sargramostim1件: Sargramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
14Homocysteine1件: Homocysteine---1件: 229 💬
15Human Bone Marrow Mesenchymal Stem Cell (hBMMSC)----1件: 229 💬
16IV Deployment Of cSVF In Sterile Normal Saline IV Solution----2件: 85, 229 💬
17LEUKINE----2件: 28, 229 💬
18Liberase Enzyme (Roche)----2件: 85, 229 💬
19Methionine1件: Methionine1件: Methionine 💬 --9件: 34, 75, 84, 93, 94, 229, 298, 300, 337 💬
20Microcannula Harvest Adipose Derived tissue stromal vascular fraction (tSVF)----2件: 85, 229 💬
21MOLGRAMOSTIM1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 229, 299 💬
22Molgramostim 300 mcg nebuliser solution1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
23Molgramostim 300 µg nebulizer solution1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
24Molgramostim Nebuliser solution 300 mcg1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
25Molgramostim nebulizer solution1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬2件: 229, 299 💬
26Molgramostim Open-label1件: Molgramostim1件: Molgramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬1件: 229 💬
27PARI eFlow nebulizer system----2件: 229, 299 💬
28Pioglitazone1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
29Rescue WLL----1件: 229 💬
30RhGM-CSF----1件: 229 💬
31RITUXIMAB1件: Rituximab1件: Rituximab 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 💬54件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
32Sargramostim1件: Sargramostim1件: Sargramostim 💬 1件: CSF2RA 💬 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬7件: 6, 28, 60, 62, 96, 229, 285 💬
33Sterile Normal Saline for Intravenous Use----2件: 85, 229 💬
34Vitamin B12, B9, B6, C supplementation----1件: 229 💬
35Whole Lung Lavage(WLL)----1件: 229 💬